Catalyst Wire Dossier Catalyst Wire Dossier

Deltyba

delamanid · Otsuka Pharmaceutical
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Deltyba, covering 2024-06-26 to 2026-03-18. Get the full timeline:

Most recent: EMA Authorised: Deltyba (Delamanid) — Otsuka Novel Products GmbH

See pricing